Gloria Melanie 4

What Happened
Gloria Melanie, Chief Operating Officer of Immunovant, sold a total of 3,115 shares in open-market transactions on May 20, 2026, generating roughly $101,072 in proceeds. The sales break down as: 249 shares at a weighted average price of $30.41 ($7,572), 1,168 shares at $32.15 ($37,551), and 1,698 shares at $32.95 (~$55,949). These sales were reported as dispositions (transaction code S).

Key Details

• Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (filed timely for a typical two-business-day reporting window).
• Total shares sold: 3,115; total proceeds: about $101,072.
• Price details / ranges (weighted averages and reported ranges):
  • 249 shares at $30.41 (prices ranged $30.32–$31.00)
  • 1,168 shares at $32.15 (prices ranged $31.55–$32.50)
  • 1,698 shares at $32.95 (prices ranged $32.55–$33.49)
• Footnote: These sales were "sell-to-cover" transactions to satisfy tax withholding related to RSUs. On Nov 18, 2024 the reporting person was granted 109,956 RSUs; 6,872 of those RSUs vested on May 18, 2026, and the issuer mandated selling shares to cover taxes (not a discretionary sale).
• Shares owned after the transactions: not specified in the provided filing summary.

Context
This was a sell-to-cover tied to RSU vesting (tax-withholding), which is routine and does not necessarily reflect the insider’s view of the company. Sales coded "S" for tax withholding are common after awards vest; purchases would typically be interpreted as a stronger bullish signal.